The United States Food and Drug Administration (FDA) has revised ‘healthy’ foods, stating that cereal, yogurt, and protein bars are no longer considered ‘healthy.
According to report, the information came in a new ruling by the FDA.
However, the FDA, in its update this week revised its definition of the term “healthy” as it pertains to packaged food products, establishing specific criteria that must be met.
The agency stated that to qualify for the “healthy” label, food products must meet specific nutritional standards.
These standards include a minimum content of essential nutrients such as protein and whole grains.
It must also limit the presence of detrimental ingredients like added sugars and saturated fats.
In addition, as a result of the revised guidelines, certain products previously labeled as “healthy,” such as high-sugar cereals, protein bars, and yogurts, will no longer meet the necessary criteria.
According to FDA officials, the updated guidelines, which mark the first revision in three decades, aim to combat and reverse the widespread prevalence of chronic diseases in America, including obesity, diabetes, and cancer.
Critics have denounced the ruling, arguing that it unjustly excludes certain foods from the “healthy” designation, despite detailed scientific evidence supporting their inclusion in a balanced diet.
About FDA
The United States Food and Drug Administration (FDA) operates as a federal agency within the Department of Health and Human Services.
Mission of FDA
The primary mission of FDA focuses on safeguarding and enhancing public health.
The FDA achieves this through rigorous oversight of various sectors, including food safety, tobacco products, dietary supplements, and both prescription and over-the-counter medications.
Functions of FDA
The agency regulates vaccines, biopharmaceuticals, blood transfusions, medical devices, cosmetics, animal feed, and veterinary products.
It enforces the Federal Food, Drug, and Cosmetic Act (FD&C), which serves as the cornerstone of its regulatory framework.
Beyond this act, the agency also implements other laws, particularly Section 361 of the Public Health Service Act.
This broader scope of enforcement includes regulations that extend beyond food and drugs.
The FDA oversees the safety of lasers, cellular phones, and even condoms.
Furthermore, the agency manages health concerns related to both household pets and human reproductive materials.
Leadership
Leadership within the FDA comes from the Commissioner of Food and Drugs, a position appointed by the President with Senate approval.
The Commissioner reports directly to the Secretary of Health and Human Services. As of February 17, 2022, Robert Califf holds the position of Commissioner.
Headquarters
The FDA’s headquarters is situated in the White Oak area of Silver Spring, Maryland.
The agency operates 223 field offices and 13 laboratories across all 50 states, the U.S. Virgin Islands, and Puerto Rico.
In 2008, the FDA began deploying staff to various countries, including China, India, and the United Kingdom, to enhance its global oversight capabilities.
Structure
The organizational structure of the FDA comprises several centers and offices, each focusing on specific areas of regulation and research.
These include the Office of the Commissioner, the Office of the Chief Counsel, and the Center for Drug Evaluation and Research (CDER), among others.
Each center plays a critical role in the FDA’s mission to ensure public health safety.
FDA Building 31 houses the Office of the Commissioner and regulatory offices, while FDA Building 66 is home to the Center for Devices and Radiological Health.
The agency’s headquarters facilities span Montgomery County and Prince George’s County in Maryland.
The FDA has operated within the White Oak Federal Research Center since 1990.
This facility occupies 130 acres and has undergone significant expansion since 2001.
The General Services Administration initiated new construction to consolidate the FDA’s various operations scattered throughout the Washington metropolitan area.
The Life Sciences Laboratory, the first building completed in this consolidation, opened in December 2003.
As of December 2018, the FDA campus supports nearly 11,000 employees spread across approximately 3.8 million square feet of office and laboratory space.
This facility includes multiple centers, such as the Center for Biologics Evaluation and Research (CBER) and the Center for Veterinary Medicine (CVM).
The FDA Reauthorization Act of 2017 projected a substantial increase in the agency’s workforce.
The FDA anticipates growing its employee count by 64% over the next 15 years, aiming for a total of 18,000 employees.
To accommodate this growth, the agency plans to add around 1.6 million square feet of new office and specialized space.
The National Capital Planning Commission approved a new master plan for this expansion in December 2018, with construction expected to conclude by 2035, contingent on funding appropriations.
In summary, the FDA plays a vital role in public health through its comprehensive regulatory oversight.
With its expansive facilities, dedicated workforce, and evolving mission, the agency remains committed to ensuring the safety and efficacy of food, drugs, and various health-related products.